1999
DOI: 10.1086/302335
|View full text |Cite
|
Sign up to set email alerts
|

Different Functional Outcome of RetGC1 and RPE65 Gene Mutations in Leber Congenital Amaurosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
64
0
1

Year Published

2000
2000
2007
2007

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 105 publications
(70 citation statements)
references
References 13 publications
(14 reference statements)
5
64
0
1
Order By: Relevance
“…15 Indeed, photoreceptor cells normally convert light energy into an electrical signal through a transduction process that consists of an enzymatic cascade, resulting in the hydrolysis of cGMP and the closure of cGMP-gated cation channels with hyperpolarisation of the plasma membrane. [16][17][18] The discovery of missense and frameshift retGC-1 mutations suggests that cGMP production in photoreceptor cells is abolished in LCA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…15 Indeed, photoreceptor cells normally convert light energy into an electrical signal through a transduction process that consists of an enzymatic cascade, resulting in the hydrolysis of cGMP and the closure of cGMP-gated cation channels with hyperpolarisation of the plasma membrane. [16][17][18] The discovery of missense and frameshift retGC-1 mutations suggests that cGMP production in photoreceptor cells is abolished in LCA.…”
Section: Discussionmentioning
confidence: 99%
“…14 The search for genotype-phenotype correlations allowed us to demonstrate that retGC1 gene mutations are responsible for a congenital cone-rod dystrophy with dramatic and invariable cone dysfunction, while RPE65 gene mutations are responsible for a severe yet progressive rod-cone dystrophy, still different from the congenital stationary blindness caused by retGC1 gene mutations. 15 Here we report the study of retGC1 gene in 118 LCA patients. A total of 21 different mutations were identified in 24 unrelated families.…”
Section: Introductionmentioning
confidence: 96%
“…Nystagmus and keratoconus have also been documented in patients with Leber congenital amaurosis due to CRX mutations [Sohocki et al, 1998;Jacobson et al, 1998;Dharmaraj et al, 2000;Rivolta et al, 2001]. Patients with Leber congenital amaurosis due to mutations in other genes also can have hyperopia, nystagmus, and keratoconus [Perrault et al, 1999;Lotery et al, 2000;Dharmaraj et al, 2000;Hameed et al, 2000], and thus these ocular abnormalities are not specific to CRX mutations. To determine if patients with CRX mutations causing cone-rod degeneration or retinitis pigmentosa also have a hyperopic refractive error, we tabulated the refractive errors from such cases described in the literature.…”
Section: Clinical Relevancementioning
confidence: 99%
“…40% of LCA) and a severe yet progressive rod-cone dystrophy (Type II; ca. 60%) [Perrault et al, 1999;Hanein et al, 2004]. Up to date, 13 LCA genes have been mapped, 10 of which have been identified: GUCY2D/retGC1 [Perrault et al, 1996], RPE65 [Marlhens et al, 1997], CRX [Swaroop et al, 1999], AIPL1 [Sohocki et al, 2000], RPGRIP1 [Dryja et al, 2001;Gerber et al, 2001], CRB1 [den Hollander et al, 2001;Gerber et al, 2002], LRAT [Thompson and Gal, 2003], TULP1 , RDH12 [Janecke et al, 2004;Perrault et al, 2004], CEP290 [den Hollander et al, 2006;Perrault et al, 2007].…”
Section: Introductionmentioning
confidence: 99%
“…Up to date, 13 LCA genes have been mapped, 10 of which have been identified: GUCY2D/retGC1 [Perrault et al, 1996], RPE65 [Marlhens et al, 1997], CRX [Swaroop et al, 1999], AIPL1 [Sohocki et al, 2000], RPGRIP1 [Dryja et al, 2001;Gerber et al, 2001], CRB1 [den Hollander et al, 2001;Gerber et al, 2002], LRAT [Thompson and Gal, 2003], TULP1 , RDH12 [Janecke et al, 2004;Perrault et al, 2004], CEP290 [den Hollander et al, 2006;Perrault et al, 2007]. Mutations in 3/10of them were shown to account for LCA type I (GUCY2D, RPGRIP1, CEP290) while, although less frequent, LCA type II was hitherto accounted for by mutations in 7/10 genes (RPE65, CRX, AIPL1, CRB1, LRAT TULP12, RDH12) [Perrault et al, 1999;Hanein et al, 2004;Perrault et al, 2004;Perrault et al, 2007].…”
Section: Introductionmentioning
confidence: 99%